FDA appropriation moves to committee
This article was originally published in The Tan Sheet
Executive SummaryA House Appropriations subcommittee approves funding for FDA that matches the Obama administration's fiscal 2010 FDA budget request of $2.35 billion in direct appropriations, a 14.6 percent increase over the fiscal 2009 level. During a June 11 markup on appropriations for the Department of Agriculture and FDA, Subcommittee Chairwoman Rosa DeLauro, D-Conn., noted that with user fees, FDA's appropriation increases $373 million to almost $3 billion, which "will help to reform and significantly improve how the agency ensures food and medical product safety" (1"The Tan Sheet" May 25, 2009, p. 3). Appropriations Chairman David Obey, D-Wis., scheduled the USDA and FDA appropriation markup for June 18
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.